Electronic Physician is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE). The COPE’s code of conduct guidelines are available at: http://www.publicationethics.org

Electronic Physician has zero tolerance for academic misconduct, including "Duplicate Publication," "Salami Publication," "Plagiarism", "Fake Submissions", "Ghost Authorship", "Fabrication of Data", and "Fake External Reviewer Suggestions". All manuscripts are investigated thoroughly regarding any potential unethical conduct. All of the required documents about the research (clinical trial registration ID, research ethics approval, authorization letter for publishing case reports, etc.) are required. Regarding the plagiarism, all submissions will be checked for potential copy-paste jobs using iThenticate.

Part A. Editor’s Responsibilities:

A.1. Publication decisions

Editor-in-Chief of the journal is responsible for deciding which of the manuscripts should be published. Editors and reviewers treat all manuscripts as confidential documents do not show to or discussed with others except if authorized by the editor. 

 

A.2. Fair play

The editor evaluate manuscripts for their intellectual content without regard to the nature of the authors or the host institution including race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

 

A.3. Confidentiality

The editors and editorial staff must not disclose any information about manuscripts to anyone other than the corresponding author, reviewers, potential reviewers, and other editorial advisers as appropriate. In the case of a misconduct investigation, the editor-in-chief may disclose material to third parties (e.g., an institutional investigation committee or other editors). 

 

A.4. Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research.

 

A.5. Corrections and retractions

When genuine errors in published work are pointed out by readers, authors, or editors, a correction will be published as soon as possible. If the error renders the work or substantial parts of it invalid, the paper should be retracted with an explanation as to the reason for retraction.

Regarding the retraction of published items and corrections we follow the COPE  and ICMJE guidelines that can be found here:

https://publicationethics.org/retraction-guidelines

and:

http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html

 

A.6. Ensuring the integrity of the published record

If serious concerns are raised by readers, reviewers, or others, about the conduct, validity, or reporting of academic work, the editor-in-chief will initially contact the authors and allow them to respond to the concerns. If that response is unsatisfactory, the journal will take this to the institutional level. In cases when concerns are very serious and the published work is likely to influence clinical practice or public health, the journal may consider informing readers about these concerns, while the investigation is ongoing. Once an investigation is concluded the journal will publish comment that explains the findings of the investigation. Editor-in-chief may decide to retract a paper if a serious misconduct has happened even if an investigation by an institution or national body does not recommend it.

 

Part B. Reviewers’ responsibilities:

B.1. Contribution to Editorial Decisions

Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Reviewers are expected to provide constructive comments on the manuscript that help the author(s) to revise the manuscript in higher standards and quality.

 

B.2. Promptness

Reviewers that feel unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

 

B.3. Confidentiality

The reviewers should treat as confidential document any manuscripts received for review. They manuscript should not be shown to or discussed with others except as authorized by the editor.

 

B.4. Standards of Objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

 

B.5. Acknowledgement of Sources

Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

 

B.6. Disclosure and Conflict of Interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

 

B.7. Reviewer misconduct

Electronic physician will take reviewer misconduct seriously and pursue any allegation of breach of confidentiality, non-declaration of conflicts of interest (financial or non-financial), inappropriate use of confidential material, or delay of peer review for competitive advantage. 

 

Pat C. Authors responsibilities:

C.1.Reporting standards

Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

 

C.2. Data Access and Retention

Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data and should in any event be prepared to retain such data for a reasonable time after publication.

 

C.3. Originality and Plagiarism

Electronic physician checks the originality of the manuscripts by iThenticate and presents the “Similarity Report” to the authors. Authors should ensure that submitted work is original and has not been published elsewhere in any language, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted. Applicable copyright laws and conventions should be followed. Copyright material (e.g. tables, figures or extensive quotations) should be reproduced only with appropriate permission and acknowledgement. 

 

C.4. Multiple, Redundant or Concurrent Publication

Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.

 

C.5. Acknowledgement of Sources

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

 

C.6. Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication. International Committee of Medical Journal Editors recommends the authorship criteria at: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html  

 

C.7. Individual and organizational acknowledgments:

All of the individuals or organizations that made a contribution to the work but they do not meet the criteria for authorship, should be acknowledged in the acknowledgments section of the manuscript. The corresponding author should not acknowledge any individual or organization without a written permission.

 

C.8. Hazards

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

 

C.9. Reporting of research involving humans or animals

Appropriate approval, licensing or registration should be obtained before the research begins and details should be provided in the report (e.g. Institutional Review Board, Research Ethics Committee approval, national licensing authorities for the use of animals). If requested by editors, authors should supply evidence that reported research received the appropriate approval and was carried out ethically (e.g. copies of approvals, licenses, participant consent forms). Researchers should not generally publish or share identifiable individual data collected in the course of research without specific consent from the individual (or their representative).

All the procedures in studies on human must be in conformity with the Declaration of Helsinki and approved by the local Human Research Ethics Committee. Appropriate approval, licensing or registration should be obtained before the research begins and details should be provided in the report (e.g. Institutional Review Board, Research Ethics Committee approval, national licensing authorities for the use of animals). Authors should supply evidence that reported research received the appropriate approval and was carried out ethically (e.g. copies of approvals, licenses, participant consent forms). Researchers should not generally publish or share identifiable individual data collected in the course of research without specific consent from the individual (or their representative). The researchers must obtain informed consent from all participants (or their parents in the case of pediatrics research).

 

C.10. Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

 

C.11. Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. 

The  most recent editorial (June 2021)

Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?

An editorial by Dr. Mehrdad Jalalian

Read more.


The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

 

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here

 


Our previous editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:


Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: